deferiprone has been researched along with azacitidine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Datta, S | 1 |
Jones, J; Martinez, S; Moraleda, JM; Quesada, MP; RodrÃguez-Lozano, FJ | 1 |
3 other study(ies) available for deferiprone and azacitidine
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Treatment of thalassoemia--the current scenario.
Topics: Azacitidine; Bone Marrow Transplantation; Deferiprone; Fetal Hemoglobin; Genetic Therapy; Humans; Hydroxyurea; Iron Chelating Agents; Pyridones; Thalassemia | 2002 |
Novel aberrant genetic and epigenetic events in Friedreich's ataxia.
Topics: Antioxidants; Apoptosis; Azacitidine; Brain-Derived Neurotrophic Factor; Caspase 3; Cells, Cultured; Decitabine; Deferiprone; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenesis, Genetic; Frataxin; Friedreich Ataxia; Gene Expression Profiling; Humans; Iron Chelating Agents; Iron-Binding Proteins; MicroRNAs; Neuregulin-1; Oxidative Stress; Periodontal Ligament; Pyridones; Superoxide Dismutase; Ubiquinone | 2015 |